Cargando…

Protocol for 3D Bioprinting Mesenchymal Stem Cell–derived Neural Tissues Using a Fibrin-based Bioink

Three-dimensional bioprinting utilizes additive manufacturing processes that combine cells and a bioink to create living tissue models that mimic tissues found in vivo. Stem cells can regenerate and differentiate into specialized cell types, making them valuable for research concerning degenerative...

Descripción completa

Detalles Bibliográficos
Autores principales: Perez, Milena Restan, Masri, Nadia Z, Walters-Shumka, Jonathan, Kahale, Sarah, Willerth, Stephanie M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bio-Protocol 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176209/
https://www.ncbi.nlm.nih.gov/pubmed/37188103
http://dx.doi.org/10.21769/BioProtoc.4663
_version_ 1785040382680104960
author Perez, Milena Restan
Masri, Nadia Z
Walters-Shumka, Jonathan
Kahale, Sarah
Willerth, Stephanie M.
author_facet Perez, Milena Restan
Masri, Nadia Z
Walters-Shumka, Jonathan
Kahale, Sarah
Willerth, Stephanie M.
author_sort Perez, Milena Restan
collection PubMed
description Three-dimensional bioprinting utilizes additive manufacturing processes that combine cells and a bioink to create living tissue models that mimic tissues found in vivo. Stem cells can regenerate and differentiate into specialized cell types, making them valuable for research concerning degenerative diseases and their potential treatments. 3D bioprinting stem cell–derived tissues have an advantage over other cell types because they can be expanded in large quantities and then differentiated to multiple cell types. Using patient-derived stem cells also enables a personalized medicine approach to the study of disease progression. In particular, mesenchymal stem cells (MSC) are an attractive cell type for bioprinting because they are easier to obtain from patients in comparison to pluripotent stem cells, and their robust characteristics make them desirable for bioprinting. Currently, both MSC bioprinting protocols and cell culturing protocols exist separately, but there is a lack of literature that combines the culturing of the cells with the bioprinting process. This protocol aims to bridge that gap by describing the bioprinting process in detail, starting with how to culture cells pre-printing, to 3D bioprinting the cells, and finally to the culturing process post-printing. Here, we outline the process of culturing MSCs to produce cells for 3D bioprinting. We also describe the process of preparing Axolotl Biosciences TissuePrint - High Viscosity (HV) and Low Viscosity (LV) bioink, the incorporation of MSCs to the bioink, setting up the BIO X and the Aspect RX1 bioprinters, and necessary computer-aided design (CAD) files. We also detail the differentiation of 2D and 3D cell cultures of MSC to dopaminergic neurons, including media preparation. We have also included the protocols for viability, immunocytochemistry, electrophysiology, and performing a dopamine enzyme-linked immunosorbent assay (ELISA), along with the statistical analysis. Graphical overview [Image: see text]
format Online
Article
Text
id pubmed-10176209
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Bio-Protocol
record_format MEDLINE/PubMed
spelling pubmed-101762092023-05-13 Protocol for 3D Bioprinting Mesenchymal Stem Cell–derived Neural Tissues Using a Fibrin-based Bioink Perez, Milena Restan Masri, Nadia Z Walters-Shumka, Jonathan Kahale, Sarah Willerth, Stephanie M. Bio Protoc Methods Article Three-dimensional bioprinting utilizes additive manufacturing processes that combine cells and a bioink to create living tissue models that mimic tissues found in vivo. Stem cells can regenerate and differentiate into specialized cell types, making them valuable for research concerning degenerative diseases and their potential treatments. 3D bioprinting stem cell–derived tissues have an advantage over other cell types because they can be expanded in large quantities and then differentiated to multiple cell types. Using patient-derived stem cells also enables a personalized medicine approach to the study of disease progression. In particular, mesenchymal stem cells (MSC) are an attractive cell type for bioprinting because they are easier to obtain from patients in comparison to pluripotent stem cells, and their robust characteristics make them desirable for bioprinting. Currently, both MSC bioprinting protocols and cell culturing protocols exist separately, but there is a lack of literature that combines the culturing of the cells with the bioprinting process. This protocol aims to bridge that gap by describing the bioprinting process in detail, starting with how to culture cells pre-printing, to 3D bioprinting the cells, and finally to the culturing process post-printing. Here, we outline the process of culturing MSCs to produce cells for 3D bioprinting. We also describe the process of preparing Axolotl Biosciences TissuePrint - High Viscosity (HV) and Low Viscosity (LV) bioink, the incorporation of MSCs to the bioink, setting up the BIO X and the Aspect RX1 bioprinters, and necessary computer-aided design (CAD) files. We also detail the differentiation of 2D and 3D cell cultures of MSC to dopaminergic neurons, including media preparation. We have also included the protocols for viability, immunocytochemistry, electrophysiology, and performing a dopamine enzyme-linked immunosorbent assay (ELISA), along with the statistical analysis. Graphical overview [Image: see text] Bio-Protocol 2023-05-05 /pmc/articles/PMC10176209/ /pubmed/37188103 http://dx.doi.org/10.21769/BioProtoc.4663 Text en Copyright © 2023 The Authors; exclusive licensee Bio-protocol LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Methods Article
Perez, Milena Restan
Masri, Nadia Z
Walters-Shumka, Jonathan
Kahale, Sarah
Willerth, Stephanie M.
Protocol for 3D Bioprinting Mesenchymal Stem Cell–derived Neural Tissues Using a Fibrin-based Bioink
title Protocol for 3D Bioprinting Mesenchymal Stem Cell–derived Neural Tissues Using a Fibrin-based Bioink
title_full Protocol for 3D Bioprinting Mesenchymal Stem Cell–derived Neural Tissues Using a Fibrin-based Bioink
title_fullStr Protocol for 3D Bioprinting Mesenchymal Stem Cell–derived Neural Tissues Using a Fibrin-based Bioink
title_full_unstemmed Protocol for 3D Bioprinting Mesenchymal Stem Cell–derived Neural Tissues Using a Fibrin-based Bioink
title_short Protocol for 3D Bioprinting Mesenchymal Stem Cell–derived Neural Tissues Using a Fibrin-based Bioink
title_sort protocol for 3d bioprinting mesenchymal stem cell–derived neural tissues using a fibrin-based bioink
topic Methods Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176209/
https://www.ncbi.nlm.nih.gov/pubmed/37188103
http://dx.doi.org/10.21769/BioProtoc.4663
work_keys_str_mv AT perezmilenarestan protocolfor3dbioprintingmesenchymalstemcellderivedneuraltissuesusingafibrinbasedbioink
AT masrinadiaz protocolfor3dbioprintingmesenchymalstemcellderivedneuraltissuesusingafibrinbasedbioink
AT waltersshumkajonathan protocolfor3dbioprintingmesenchymalstemcellderivedneuraltissuesusingafibrinbasedbioink
AT kahalesarah protocolfor3dbioprintingmesenchymalstemcellderivedneuraltissuesusingafibrinbasedbioink
AT willerthstephaniem protocolfor3dbioprintingmesenchymalstemcellderivedneuraltissuesusingafibrinbasedbioink